Phase I Study of QLS1510 Tablets in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Randomized, Double‐Blind, Placebo‐Controlled, Single and Multiple AscendingDose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, andPharmacodynamics of QLS1510 in Healthy participants
Epistemonikos ID: f9d75a3853b229d02a63e86f7d02d06262dd0ee1
First added on: Aug 12, 2026